Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies

Papagianis, P, Pillow, J and Moss, T 2019, 'Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies', Paediatric Respiratory Reviews, vol. 30, pp. 34-41.


Document type: Journal Article
Collection: Journal Articles

Title Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies
Author(s) Papagianis, P
Pillow, J
Moss, T
Year 2019
Journal name Paediatric Respiratory Reviews
Volume number 30
Start page 34
End page 41
Total pages 8
Publisher Elsevier
Abstract Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.
Subject Respiratory Diseases
Keyword(s) Bronchopulmonary dysplasia
Chorioamnionitis
Dexamethasone
Glucocorticoid
Inflammation
Pulmonary
DOI - identifier 10.1016/j.prrv.2018.07.007
Copyright notice © 2018 Elsevier Ltd. All rights reserved.
ISSN 1526-0542
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 6 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 2 Abstract Views  -  Detailed Statistics
Created: Tue, 06 Aug 2019, 08:28:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us